Press release
PD-L1 and PIK3CA Testing Product Market Grows with Rise in Precision Oncology & Targeted Cancer Therapies | CAGR of 18.45%
PD-L1 and PIK3CA Testing Product Market
Market growth opportunities(2025-2031):
The testing market is expanding as demand for PD‐L1 and PIK3CA biomarkers grows in oncology diagnostics and companion diagnostics. Multiplex assay platforms integrating both markers are gaining traction in trials and clinical workflows. Point-of-care and decentralized diagnostics are emerging, offering faster turn-around and broader access. Expanded precision oncology and targeted therapy approvals are fueling uptake. Adoption in emerging markets is accelerating thanks to improving diagnostics infrastructure and greater cancer awareness
Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/pd-l1-and-pik3ca-testing-product-market?sp
PD-L1 and PIK3CA Testing Product Market: Recent Industry Developments
✅ In April 2025, Agilent PD L1 IHC 22C3 pharmDx assay received European IVDR certification as a companion diagnostic for identifying gastric/gastroesophageal junction adenocarcinoma patients eligible for pembrolizumab (Keytruda®). It is now certified for seven cancer indications across EU diagnostics laboratories
✅ In December 2024, Agilent's PD L1 IHC 28 8 pharmDx assay secured Class C IVDR certification in Europe, expanding its diagnostic use across nine cancer types including NSCLC, urothelial carcinoma, melanoma, esophageal and gastric cancers enhancing confidence in PD L1 guided immunotherapy selection
✅ Roche's VENTANA PD L1 (SP263) Assay was FDA approved in October 2021 as a companion diagnostic to identify NSCLC patients suitable for Tecentriq® (atezolizumab) adjuvant therapy Mbased on the IMpower010 study showing reduced recurrence risk
✅ For PIK3CA mutations, Roche offers the cobas® PIK3CA Mutation Test kit (RUO), enabling real time PCR detection of mutations in exons 1, 4, 7, 9, and 20 from FFPE samples with >95 % reliability primarily for research use
✅ In October 2024, FDA approved inavolisib (Itovebi®) for PIK3CA mutant breast cancer, using FoundationOne Liquid CDx as the companion diagnostic to identify eligible patients marking a significant therapeutic and diagnostic linkage for targeted PI3K inhibitor use
PD-L1 and PIK3CA Testing Product Market: Drivers
Rapid growth in immunotherapies targeting the PD‐1/PD‐L1 axis and PI3K inhibitors is driving demand for accurate testing. Precision medicine mandates biomarker stratification for targeted treatments. Companion diagnostics integration and regulatory trial requirements bolster market relevance. Advanced molecular platforms (IHC, NGS) and industry collaborations further support demand. Standardization and quality assurance remain key to clinical trust and broader adoption
Strategic Players Driving the PD-L1 and PIK3CA Testing Product Market Forward:
F. Hoffmann-La Roche Ltd, Agilent Technologies, QIAGEN, EntroGen, Inc., Amoy Diagnostics, ACCB Biotech, Myriad Genetic Laboratories, Inc. and FOUNDATION MEDICINE, INC.
Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/pd-l1-and-pik3ca-testing-product-market?sp
Segment Covered in the PD-L1 and PIK3CA Testing Product Market:
➥By Product Type: PD-L1, Cervical Cancer, Esophageal Cancer, NSCLC-Squamous, Squamous Cell Carcinoma of the Head and Neck, Triple-Negative Breast Cancer, Urothelial Carcinoma, PIK3CA
➥By End-User: Hospital, Diagnostic Center, Cancer Center, Others
Regional Analysis for PD-L1 and PIK3CA Testing Product Market:
North America currently dominates global market share, supported by mature oncology infrastructure and strong clinical research activity. Europe takes the second‐largest share with widespread diagnostic adoption and reimbursement support. Asia‐Pacific represents the fastest-growing region, fueled by rising cancer prevalence, improving healthcare access, and expanding precision oncology awareness
Why Purchase the Report for PD-L1 and PIK3CA Testing Product Market?:
➠ Technology & Innovation: Tracks clinical trials and upcoming pharmaceutical advancements to stay ahead in product development.
➠ Market Positioning & Competitive Strategy: Analyzes product performance, market share, and competitor tactics for strategic decision-making.
➠ Real-World Evidence & Physician Insights: Incorporates patient data and physician behavior to align products with actual healthcare needs.
➠ Pricing & Market Access: Reviews reimbursement trends and access models to optimize product pricing and launch strategies.
➠ Regulatory & Industry Shifts: Covers policy changes, health system dynamics, and technology trends impacting market opportunities.
➠ Regional Growth & Expansion: Identifies high-growth markets and investment opportunities for geographic expansion.
Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=pd-l1-and-pik3ca-testing-product-market?sp
Conclusion:
The PD‐L1 and PIK3CA testing product market is entering a period of robust growth as precision oncology expands. Multiplex biomarker panels and decentralized testing platforms will increase accessibility and ease integration into clinical workflows. North America and Europe are current leaders, while Asia‐Pacific is poised to deliver rapid growth. Market success will rely on innovations in assay standardization, reagent performance, regulatory alignment, and partnerships with pharma and diagnostics providers
Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sp
✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends
Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release PD-L1 and PIK3CA Testing Product Market Grows with Rise in Precision Oncology & Targeted Cancer Therapies | CAGR of 18.45% here
News-ID: 4131229 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
United States Hyperammonemia Market 2025 | Growth Drivers, Trends & Market Forec …
Market Size and Growth
Global Hyperammonemia Market is expected to reach at a Significant CAGR during the forecast period 2024-2031.
Key Development:
United States: Recent Industry Developments
✅ July 2025: Amogy secured an additional $23 million in venture financing, bringing its total funding to $80 million. This investment aims to accelerate the company's growth and advance its ammonia-to-power solutions.
✅ July 2025: Navigator Gas announced a joint venture with Amon Maritime to construct two ammonia-fueled…
United States Internet of Things (IoT) in Agriculture Market 2025 | Growth Drive …
Market Size and Growth
Global Internet of Things (IoT) in Agriculture Market reached US$ 31.10 billion in 2023 and is expected to reach US$ 83.26 billion by 2031, growing with a CAGR of 13.1% during the forecast period 2024-2031.
Recent Mergers and Acquisitions:
United States:
✅ In Sep 2025, Sensei Farms (U.S.), backed by Larry Ellison, acquired ~25 acres in Lockhart, Texas - the former facility of robotics-farming company Iron Ox. While…
United States Medical Device Coatings Market 2025 | Growth Drivers, Key Players …
Market Size and Growth
Medical device coatings market is growing at a High CAGR during the forecast period 2024-2031.
Recent Mergers and Acquisitions:
United States: Recent Medical Device Coatings Developments
✅ In April 2025, the FDA granted 510(k) clearance to Becton Dickinson's CentroVena One central venous catheter, which features an advanced hydrophilic coating to improve device performance.
✅ In March 2025, the U.S. FTC filed suit to block GTCR's planned $627M acquisition of Surmodics…
United States Nephrotic Syndrome Drugs Market 2025 | Growth Drivers, Trends & Ma …
Market Size and Growth
The global nephrotic syndrome drugs market reached US$ 423.7 million in 2023 and is expected to reach US$ 645.3 million by 2030, growing with a CAGR of 5.4% during the forecast period 2024-2031.
Recent Mergers and Acquisitions:
United States:
✅ In June 2025, Biogen initiated a Phase 3 study of felzartamab for the treatment of primary membranous nephropathy, a common cause of nephrotic syndrome. This trial aims to…
More Releases for PIK3CA
PD-L1 And PIK3CA Testing Product Market Size by Type, Application, and Regional …
According to Market Research Intellect, the global PD-L1 And PIK3CA Testing Product market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period.
The PD-L1 and PIK3CA testing product market is experiencing strong growth due to rising demand…
PD-L1 and PIK3CA Testing Product Market Comprehensive Study: Growth Outlook and …
The PD-L1 and PIK3CA Testing Product Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants to capitalize on these opportunities. Overall, the PD-L1 and PIK3CA Testing Product market report is an essential resource for market participants who are looking to gain a comprehensive understanding of the market…
PD-L1 and PIK3CA Testing Product Market Statistical Forecast, Trade Analysis 202 …
The PD-L1 and PIK3CA testing product market is anticipated to achieve a CAGR of 18.45% by 2031.
Will the PD-L1 and PIK3CA Testing Product market emerge as the sector's next great thing? To discover the answer, look at the PD-L1 and PIK3CA Testing Product market analysis and projections. In-depth insight of the opportunities, difficulties, and trends now impacting the Machinery landscape is provided by this market research study, empowering industry participants…
PD-L1 and PIK3CA Testing market size increases with a CAGR of 19.7% during 2023- …
The global PD-L1 and PIK3CA Testing market size was valued at USD 536.9 million in 2022 and is forecast to a readjusted size of USD 1892 million by 2029 with a CAGR of 19.7% during review period. The global market for PD-L1 and PIK3CA testing is experiencing significant growth, driven by the increasing demand for personalized cancer diagnostics and the rising incidence of cancer worldwide. Report provides comprehensive insights into…
PD-L1 and PIK3CA Testing Market Set to Surpass USD 2,438.4 Million by 2030 | Roc …
The latest report by Congruence Market Insights, titled 'Global PD-L1 and PIK3CA Testing Market - Size, Trends, Share, Growth, Dynamics, Competition, and Opportunity Forecast, 2023 - 2030,' provides a thorough analysis of the global PD-L1 and PIK3CA Testing market. The report meticulously examines both macro and micro trends, offering insights into the dynamic factors influencing the market. It encompasses a detailed exploration of qualitative and quantitative aspects, delivering a precise…
PD-L1 and PIK3CA Testing Product Market to Eyewitness Massive Growth by 2028 | A …
The Latest Released PD-L1 and PIK3CA Testing Product market study has evaluated the future growth potential of PD-L1 and PIK3CA Testing Product market and provides information and useful stats on market structure and size. The report is intended to provide market intelligence and strategic insights to help decision-makers take sound investment decisions and identify potential gaps and growth opportunities. Additionally, the report also identifies and analyses changing dynamics, and emerging…
